Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed-Reference-Cited by-同舟云学术

Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed

Published:2023-05-11 Issue:5 Volume:13 Page:813
ISSN:2075-4426
Container-title:Journal of Personalized Medicine
language:en
Short-container-title:JPM

Author:

Di Paola Rossella¹,De Ananya¹^ORCID,Capasso Anna²,Giuliana Sofia³,Ranieri Roberta³,Ruosi Carolina³,Sciarra Antonella⁴,Vitagliano Caterina³,Perna Alessandra F.⁵^ORCID,Capasso Giovambattista⁶,Simeoni Mariadelina⁵^ORCID

Affiliation:

1. Department of Mental and Physical Health and Preventive Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy

2. Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas, Austin, TX 75063, USA

3. Nephrology Unit, Department of Specialist General Surgery, University Hospital “Luigi Vanvitelli”, 80131 Naples, Italy

4. Department of Oncologic Surgery, Translational Medical Sciences at University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy

5. Nephrology and Dialysis Unit, Department of Translational Medical Sciences at University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy

6. Biogem S.c.a.r.l. Research Institute, 83031 Ariano Irpino, Italy

Abstract

Thyroid cancers require complex and heterogeneous therapies with different impacts on renal function. In our systematic literature review, we analyzed several aspects: renal function assessment, the impact of radiotherapy and thyroid surgery on kidney functioning, and mechanisms of nephrotoxicity of different chemotherapy, targeted and immunologic drugs. Our study revealed that the renal impact of thyroid cancer therapy can be a limiting factor in all radiotherapy, surgery, and pharmacological approaches. It is advisable to conduct a careful nephrological follow-up imposing the application of body surface based estimated Glomerular Filtration Rate (eGFR) formulas for the purpose of an early diagnosis and treatment of renal failure, guaranteeing the therapy continuation to thyroid cancer patients.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Link

https://www.mdpi.com/2075-4426/13/5/813/pdf

Reference86 articles.

1. Schmidbauer, B., Menhart, K., Hellwig, D., and Grosse, J. (2017). Differentiated Thyroid Cancer—Treatment: State of the Art. Int. J. Mol. Sci., 18.

2. Lorusso, L., Cappagli, V., Valerio, L., Giani, C., Viola, D., Puleo, L., Gambale, C., Minaldi, E., Campopiano, M.C., and Matrone, A. (2021). Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities. Int. J. Mol. Sci., 22.

3. Greco, M., Foti, D.P., Aversa, A., Fuiano, G., Brunetti, A., and Simeoni, M. (2020). Cystatin C, a Controversial Biomarker in Hypothyroid Patients under Levothyroxine Therapy: THYRenal, a Pilot Cohort Observational Study. J. Clin. Med., 9.

4. The correct renal function evaluation in patients with thyroid dysfunction;Simeoni;J. Endocrinol. Investig.,2016

5. How to improve duration and efficiency of the antiproteinuric response to Ramipril: RamiPROT—A prospective cohort study;Cianfrone;J. Nephrol.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant dysregulation of lipid metabolism in patients with papillary thyroid carcinoma after thyroidectomy;Frontiers in Endocrinology;2023-10-12